Novel genomic technologies in the NHS (completed)
From October 2006 to July 2010 Sarah Wordsworth undertook a programme of methodological and applied research on the economic evaluation of novel genomic technologies in the NHS, with a post-doctoral fellowship from the NIHR.
This research used patient level data, published literature and primary data collection to construct health economic models for use in evaluating the effectiveness and cost-effectiveness of using genomic information in healthcare.
Since August 2011, Sarah has undertaken projects with the NIHR funded Oxford Biomedical Research Centre to explore the costs and benefits of using high-throughput, so called next-generation, sequencing technologies in the NHS. These technologies have the ability to screen many genes simultaneously, but are considered very expensive.